Zobrazeno 1 - 10 of 692 pro vyhledávání: '"Gadal, S."'
2
Akademický článek
A Next-Generation BRAF Inhibitor Overcomes Resistance to BRAF Inhibition in Patients with BRAF-Mutant Cancers Using Pharmacokinetics-Informed Dose Escalation.
Autor: Yaeger R; Memorial Sloan Kettering Cancer Center, New York, New York., McKean MA; Sarah Cannon Research Institute, Nashville, Tennessee., Haq R; Dana Farber Cancer Institute, Boston, Massachusetts., Beck JT; Highlands Oncology, Fayetteville, Arkansas., Taylor MH; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon., Cohen JE; Hadassah Medical Center, Jerusalem, Israel., Bowles DW; University of Colorado Hospital, Aurora, Colorado., Gadgeel SM; Henry Ford Health System, Detroit, Michigan., Mihalcioiu C; McGill University Health Centre, Montreal, Canada., Papadopoulos KP; South Texas Accelerated Research Therapeutics, San Antonio, Texas., Diamond EL; Memorial Sloan Kettering Cancer Center, New York, New York., Sturtz KB; Pfizer Boulder Research and Development, Boulder, Colorado., Feng G; Pfizer Early Clinical Development, Cambridge, Massachusetts., Drescher SK; Pfizer Boulder Research and Development, Boulder, Colorado., Reddy MB; Pfizer Boulder Research and Development, Boulder, Colorado., Sengupta B; Pfizer Boulder Research and Development, Boulder, Colorado., Maity AK; Pfizer Early Clinical Development, Cambridge, Massachusetts., Brown SA; Pfizer Boulder Research and Development, Boulder, Colorado., Singh A; Pfizer Boulder Research and Development, Boulder, Colorado., Brown EN; Pfizer Boulder Research and Development, Boulder, Colorado., Baer BR; Pfizer Boulder Research and Development, Boulder, Colorado., Wong J; Pfizer Boulder Research and Development, Boulder, Colorado., Mou TC; Pfizer Boulder Research and Development, Boulder, Colorado., Wu WI; Pfizer Boulder Research and Development, Boulder, Colorado., Kahn DR; Pfizer Boulder Research and Development, Boulder, Colorado., Gadal S; Memorial Sloan Kettering Cancer Center, New York, New York., Rosen N; Memorial Sloan Kettering Cancer Center, New York, New York., Gaudino JJ; Pfizer Boulder Research and Development, Boulder, Colorado., Lee PA; Pfizer Boulder Research and Development, Boulder, Colorado., Hartley DP; Pfizer Boulder Research and Development, Boulder, Colorado., Rothenberg SM; Pfizer Boulder Research and Development, Boulder, Colorado.; Pfizer Oncology Research and Development, La Jolla, California.
Publikováno v: Cancer discovery [Cancer Discov] 2024 Sep 04; Vol. 14 (9), pp. 1599-1611.
Zobrazit plný text záznamu
3
eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer.
Autor: Boyer JA; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.; Program in Molecular Pharmacology, Department of Medicine, Memorial Sloan-Kettering Cancer Center (MSKCC), New York, NY, USA.; Ludwig Institute for Cancer Research, Princeton University, Princeton, NJ, USA., Sharma M; Program in Molecular Pharmacology, Department of Medicine, Memorial Sloan-Kettering Cancer Center (MSKCC), New York, NY, USA., Dorso MA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Mai N; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Amor C; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.; Department of Cancer Biology and Genetics, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Reiter JM; Program in Molecular Pharmacology, Department of Medicine, Memorial Sloan-Kettering Cancer Center (MSKCC), New York, NY, USA., Kannan R; Department of Cancer Biology and Genetics, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gadal S; Program in Molecular Pharmacology, Department of Medicine, Memorial Sloan-Kettering Cancer Center (MSKCC), New York, NY, USA., Xu J; Program in Molecular Pharmacology, Department of Medicine, Memorial Sloan-Kettering Cancer Center (MSKCC), New York, NY, USA., Miele M; Microchemistry and Proteomics Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Li Z; Microchemistry and Proteomics Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chen X; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY 11065, USA., Chang Q; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY 11065, USA., Pareja F; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Worland S; Department of Cancer Biology, eFFECTOR Therapeutics, Inc., San Diego, CA, United States., Warner D; Department of Cancer Biology, eFFECTOR Therapeutics, Inc., San Diego, CA, United States., Sperry S; Department of Cancer Biology, eFFECTOR Therapeutics, Inc., San Diego, CA, United States., Chiang GG; Department of Cancer Biology, eFFECTOR Therapeutics, Inc., San Diego, CA, United States., Thompson PA; Department of Cancer Biology, eFFECTOR Therapeutics, Inc., San Diego, CA, United States., Yang G; The Organic Synthesis Core Facility, MSK, New York, NY, USA., Ouerfelli O; The Organic Synthesis Core Facility, MSK, New York, NY, USA., de Stanchina E; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY 11065, USA., Wendel HG; Department of Cancer Biology and Genetics, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Rosen EY; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chandarlapaty S; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Rosen N; Program in Molecular Pharmacology, Department of Medicine, Memorial Sloan-Kettering Cancer Center (MSKCC), New York, NY, USA.
Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2024 May 11. Date of Electronic Publication: 2024 May 11.
Zobrazit plný text záznamu
4
Tumorigenesis driven by the BRAF V600E oncoprotein requires secondary mutations that overcome its feedback inhibition of migration and invasion.
Autor: Gadal S; Molecular Pharmacology Program, Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA., Boyer JA; Ludwig Institute for Cancer Research, Princeton University, Princeton, NJ 08544, USA., Roy SF; Department of Dermatology, Yale University, New Haven, CT 06510, USA.; Department of Pathology, Yale University, New Haven, CT 06510, USA., Outmezguine NA; Molecular Pharmacology Program, Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA., Sharma M; Molecular Pharmacology Program, Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA., Li H; Antitumor Assessment Core Facility, Molecular Pharmacology Program, MSKCC, New York, NY 10065, USA., Fan N; Molecular Cytology Core, MSKCC, New York, NY 10065, USA., Chan E; Molecular Cytology Core, MSKCC, New York, NY 10065, USA., Romin Y; Molecular Cytology Core, MSKCC, New York, NY 10065, USA., Barlas A; Molecular Cytology Core, MSKCC, New York, NY 10065, USA., Chang Q; Antitumor Assessment Core Facility, Molecular Pharmacology Program, MSKCC, New York, NY 10065, USA., Pancholi P; Molecular Pharmacology Program, Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA., Timaul NM; Molecular Pharmacology Program, Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA., Overholtzer M; Cell Biology Program, MSKCC, New York, NY 10065, USA., Yaeger R; Department of Medicine, MSKCC, New York, NY 10065, USA., Manova-Todorova K; Molecular Cytology Core, MSKCC, New York, NY 10065, USA., de Stanchina E; Antitumor Assessment Core Facility, Molecular Pharmacology Program, MSKCC, New York, NY 10065, USA., Bosenberg M; Department of Dermatology, Yale University, New Haven, CT 06510, USA.; Department of Pathology, Yale University, New Haven, CT 06510, USA., Rosen N; Molecular Pharmacology Program, Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA.; Department of Medicine, MSKCC, New York, NY 10065, USA.; Lead Contact.
Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2024 Apr 20. Date of Electronic Publication: 2024 Apr 20.
Zobrazit plný text záznamu
5
Conference
SPATIAL ORGANISATION OF THE TRADITIONAL CULTURAL LANDSCAPE OF THE EVENKS (ON THE EXAMPLE OF SOUTH YAKUTIA).
Autor: Gadal, S.1,2, Degteva, Z.2, Danilov, I.2
Publikováno v: International Multidisciplinary Scientific Conference on Social Sciences & Arts SGEM. 2017, p89-96. 8p.
Zobrazit plný text záznamu
6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
7
Akademický článek
Multi-source datasets acquired over Toulouse (France) in 2021 for urban microclimate studies during the CAMCATT/AI4GEO field campaign.
Autor: Roupioz L; ONERA DOTA, Université de Toulouse, 2 Av. Edouard Belin BP74025, 31055, Toulouse Cedex 4, France., Briottet X; ONERA DOTA, Université de Toulouse, 2 Av. Edouard Belin BP74025, 31055, Toulouse Cedex 4, France., Adeline K; ONERA DOTA, Université de Toulouse, 2 Av. Edouard Belin BP74025, 31055, Toulouse Cedex 4, France., Al Bitar A; CESBIO, Centre d'Etudes Spatiales de la Biosphère, CNES, CNRS, INRA, IRD, UPS, 18 Av. Edouard Belin BPI 2801, 31401, Toulouse Cedex 9, France., Barbon-Dubosc D; ONERA DOTA, Université de Toulouse, 2 Av. Edouard Belin BP74025, 31055, Toulouse Cedex 4, France., Barda-Chatain R; ONERA DOTA, Université de Toulouse, 2 Av. Edouard Belin BP74025, 31055, Toulouse Cedex 4, France., Barillot P; ONERA DOTA, Université de Toulouse, 2 Av. Edouard Belin BP74025, 31055, Toulouse Cedex 4, France., Bridier S; Aix Marseille Univ, Université Côte d'Azur, Avignon Université, CNRS, ESPACE, UMR 7300, 74 rue Louis Pasteur, 84029, Avignon Cedex, France., Carroll E; Aix Marseille Univ, Université Côte d'Azur, Avignon Université, CNRS, ESPACE, UMR 7300, 74 rue Louis Pasteur, 84029, Avignon Cedex, France., Cassante C; ONERA DOTA, Université de Toulouse, 2 Av. Edouard Belin BP74025, 31055, Toulouse Cedex 4, France., Cerbelaud A; ONERA DOTA, Université de Toulouse, 2 Av. Edouard Belin BP74025, 31055, Toulouse Cedex 4, France., Déliot P; ONERA DOTA, Université de Toulouse, 2 Av. Edouard Belin BP74025, 31055, Toulouse Cedex 4, France., Doublet P; ONERA DOTA, Université de Toulouse, 2 Av. Edouard Belin BP74025, 31055, Toulouse Cedex 4, France., Dupouy PE; ONERA DOTA, Université de Toulouse, 2 Av. Edouard Belin BP74025, 31055, Toulouse Cedex 4, France., Gadal S; Aix Marseille Univ, Université Côte d'Azur, Avignon Université, CNRS, ESPACE, UMR 7300, 74 rue Louis Pasteur, 84029, Avignon Cedex, France., Guernouti S; Equipe de Recherche BPE, Cerema & LOCIE - UMR 5271, CNRS & Université Savoie, 9 Rue René Viviani BP 46223, 44262, Nantes, France., De Guilhem De Lataillade A; DGA-TA, 47 rue Saint-Jean, Balma, 31044, France., Lemonsu A; CNRM, Centre National de Recherches Météorologiques, Université de Toulouse, Météo-France, CNRS, 42 Av. Gaspard Coriolis, 31057, Toulouse Cedex 1, France., Llorens R; Global Change Unit, University of Valencia, C/Catedrático José Beltrán 2, ES-46980 Paterna, Spain., Luhahe R; ICube Laboratory, UMR 7357, CNRS-University of Strasbourg, 300 Bd Sébastien Brant CS 10413, 67412, Illkirch Cedex, France., Michel A; ONERA DOTA, Université de Toulouse, 2 Av. Edouard Belin BP74025, 31055, Toulouse Cedex 4, France., Moussous A; ONERA DOTA, Université de Toulouse, 2 Av. Edouard Belin BP74025, 31055, Toulouse Cedex 4, France., Musy M; Equipe de Recherche BPE, Cerema & LOCIE - UMR 5271, CNRS & Université Savoie, 9 Rue René Viviani BP 46223, 44262, Nantes, France., Nerry F; ICube Laboratory, UMR 7357, CNRS-University of Strasbourg, 300 Bd Sébastien Brant CS 10413, 67412, Illkirch Cedex, France., Poutier L; ONERA DOTA, Université de Toulouse, 2 Av. Edouard Belin BP74025, 31055, Toulouse Cedex 4, France., Rodler A; Equipe de Recherche BPE, Cerema & LOCIE - UMR 5271, CNRS & Université Savoie, 9 Rue René Viviani BP 46223, 44262, Nantes, France., Riviere N; ONERA DOTA, Université de Toulouse, 2 Av. Edouard Belin BP74025, 31055, Toulouse Cedex 4, France., Riviere T; ONERA DOTA, Université de Toulouse, 2 Av. Edouard Belin BP74025, 31055, Toulouse Cedex 4, France., Roujean JL; CESBIO, Centre d'Etudes Spatiales de la Biosphère, CNES, CNRS, INRA, IRD, UPS, 18 Av. Edouard Belin BPI 2801, 31401, Toulouse Cedex 9, France., Roy A; CNRM, Centre National de Recherches Météorologiques, Université de Toulouse, Météo-France, CNRS, 42 Av. Gaspard Coriolis, 31057, Toulouse Cedex 1, France., Schilling A; ONERA DOTA, Université de Toulouse, 2 Av. Edouard Belin BP74025, 31055, Toulouse Cedex 4, France., Skokovic D; Global Change Unit, University of Valencia, C/Catedrático José Beltrán 2, ES-46980 Paterna, Spain., Sobrino J; Global Change Unit, University of Valencia, C/Catedrático José Beltrán 2, ES-46980 Paterna, Spain.
Publikováno v: Data in brief [Data Brief] 2023 Apr 03; Vol. 48, pp. 109109. Date of Electronic Publication: 2023 Apr 03 (Print Publication: 2023).
Zobrazit plný text záznamu
8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
10
Toponyms of Multicultural Environment as a Source of Information about the History of the Development of the Central Yakutia
Autor: Kyunney Pestereva, Samsonova, Marianna, Ikonnikova, Anna, Gadal, S.
Publikováno v: 3rd International Multidisciplinary Scientific Conference on Social Sciences and Arts SGEM 2016
3rd International Multidisciplinary Scientific Conference on Social Sciences and Arts SGEM 2016, Aug 2016, Varna, Bulgaria. pp.587-592, ⟨10.5593/SGEMSOCIAL2016/B32/S10.076⟩
Web of Science
International audience; The Republic of Sakha (Yakutia) - the largest subject of the Russian Federation, known for its mineral resources, extreme climatic conditions, varied landscapes and living cultures of Indigenous Peoples. As part of the project
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8bd7c999bc1d043bdeb984969295d11c
https://hal-amu.archives-ouvertes.fr/hal-01401146
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje